Market Tracker

05/26 5:16pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

3.30
Delayed Data
As of May 26
 -0.10 / -2.94%
Today’s Change
2.83
Today|||52-Week Range
7.14
-19.12%
Year-to-Date
MACK Special Dividend: MACK will begin trading ex-dividend on 05/30/17 with a $1.0552 special dividend payable to shareholders of record as of 05/17/17.
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close3.40
Today’s open3.40
Day’s range3.06 - 3.42
Volume4,830,174
Average volume (3 months)2,033,841
Market cap$437.0M
Dividend yield31.98%
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+9.02%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+61.64%
P/E ratioNM
Price/Sales3.54
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...-0.33-3.15%
ASMBAssembly Biosciences...+0.30+1.18%
CRHMCRH Medical Corp+0.22+3.78%
KPTIKaryopharm Therapeut...-0.14-1.54%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 11, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$144.3M
Annual profit (last year)-$151.7M
Net profit margin-105.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Richard Peters
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts